Identification of residues crucially involved in soluble guanylate cyclase activation
Authors:
- Peter M. SchmidtPSPeter M. Schmidt
- Friederike StollFSFriederike Stoll
- Henning SchröderHSHenning Schröder
- Harald H.H.W. SchmidtHSHarald H.H.W. Schmidt
- Johannes-Peter StaschJSJohannes-Peter Stasch
- 5 July 2006
- journal article
- research article
- Published by Wiley in FEBS Letters
- Vol. 580 (17) , 4205-4213
Abstract
The ubiquitous heterodimeric nitric oxide (NO) receptor soluble guanylate cyclase (sGC) plays a key role in various signal transduction pathways. Binding of NO takes place at the prosthetic heme moiety at the N-terminus of the β1-subunit of sGC. The induced structural changes lead to an activation of the catalytic C-terminal domain of the enzyme and to an increased conversion of GTP into the second messenger cyclic GMP (cGMP). In the present work we selected and substituted different residues of the sGC heme-binding pocket based on a sGC homology model. The generated sGC variants were tested in a cGMP reporter cell for their effect on the enzyme activation by heme-dependent (NO, BAY 41-2272) stimulators and heme-independent (BAY 58-2667) activators. The use of these experimental tools allows the enzyme’s heme content to be explored in a non-invasive manner. Asp44, Asp45 and Phe74 of the β1-subunit were identified as being crucially important for functional enzyme activation. β1Asp45 may serve as a switch between different conformational states of sGC and point to a possible mechanism of action of the heme dependent sGC stimulator BAY 41-2272. Furthermore, our data shows that the activation profile of β1IIe145 Tyr is unchanged compared to the native enzyme, suggesting that Tyr145 does not confer the ability to distinguish between NO and O2. In summary, the present work further elucidated intramolecular mechanisms underlying the NO- and BAY 41-2272-mediated sGC activation and raises questions regarding the postulated role of Tyr145 for ligand discriminationKeywords
This publication has 33 references indexed in Scilit:
- cGMP signalling: from bench to bedsideEMBO Reports, 2006
- Residues stabilizing the heme moiety of the nitric oxide sensor soluble guanylate cyclaseEuropean Journal of Pharmacology, 2005
- Femtomolar Sensitivity of a NO Sensor from Clostridium botulinumScience, 2004
- Crystal structure of an oxygen-binding heme domain related to soluble guanylate cyclasesProceedings of the National Academy of Sciences, 2004
- Identification of Residues Crucially Involved in the Binding of the Heme Moiety of Soluble Guanylate CyclaseJournal of Biological Chemistry, 2004
- Soluble guanylate cyclase: an old therapeutic target re‐visitedBritish Journal of Pharmacology, 2002
- Pharmacological actions of a novel NO‐independent guanylyl cyclase stimulator, BAY 41‐8543: in vitro studiesBritish Journal of Pharmacology, 2002
- NO-independent regulatory site on soluble guanylate cyclaseNature, 2001
- Identification of Histidine 105 in the β1 Subunit of Soluble Guanylate Cyclase as the Heme Proximal LigandBiochemistry, 1998
- Mutation of His-105 in the beta 1 subunit yields a nitric oxide-insensitive form of soluble guanylyl cyclase.Proceedings of the National Academy of Sciences, 1994